Related Experiment Videos
The Medtronic-Hall prosthesis in multiple valve replacement--first results
The Thoracic and Cardiovascular Surgeon
|May 1, 1983
Summary
The Medtronic-Hall prosthesis demonstrated no thromboembolic events in multiple valve replacements. Slight hemolysis was noted, with rare periprosthetic leaks in this cardiac surgery study.
Area of Science:
- Cardiovascular Surgery
- Biomaterials Science
Background:
- The Medtronic-Hall prosthesis is utilized for valve replacement surgery.
- Multiple valve replacements present unique surgical challenges and outcomes.
- Assessing the long-term efficacy and safety of prosthetic valves is crucial.
Purpose of the Study:
- To evaluate the outcomes of multiple valve replacements using the Medtronic-Hall prosthesis.
- To analyze complications such as thromboembolism, periprosthetic leaks, and hemolysis.
Main Methods:
- Retrospective analysis of 107 patients undergoing valve replacement with the Medtronic-Hall prosthesis between January 1981 and September 1982.
- Focus on 34 patients with multiple valve replacements, including tricuspid valve procedures.
- Clinical data collection on mortality, thromboembolic events, periprosthetic leaks, and hemolysis.
Main Results:
- Two hospital deaths (5.8%) and one late death occurred.
- No thromboembolic episodes were recorded in the study cohort.
- Two instances of periprosthetic leak were identified, one associated with bacterial endocarditis.
- Constant, mild hemolysis was observed in all patients.
Conclusions:
- The Medtronic-Hall prosthesis appears safe regarding thromboembolic complications in multiple valve replacement settings.
- Periprosthetic leaks and endocarditis remain potential complications requiring vigilant monitoring.
- Mild hemolysis is a consistent finding but may not have significant hemodynamic impact.